ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Nephron Pharmaceuticals CORP.

Official 2024 U.S. DOL Form 5500 summary for Nephron Pharmaceuticals CORP. (Nephron Pharmaceuticals Corporation 401(k) Savings Plan · EIN 93-1065757 · PN 001): $18.49M net assets, 798 active participants, and $99.22 per $10,000 (99.22 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorNephron Pharmaceuticals CORP.
Filing IdentifierNephron Pharmaceuticals Corporation 401(k) Savings Plan · EIN 93-1065757 · PN 001
Plan Category & State401(k) Defined Contribution (SC)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$18.49M
Active Participants798
Direct Admin Fee Rate$99.22 per $10,000 (99.22 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($760,638, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI